Financials
Financial year 2025
Dr. S Buggenhout, Reumatoloog from Sint-Niklaas, company number BE0757628002, closed financial year 2025 with a result of € 204,689 after tax. For that financial year Dr. S Buggenhout, Reumatoloog recorded a gross margin of € 278,935 and equity of € 205,689. Compared with financial year 2024, the result moved from € 140,416 to € 204,689. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.
€ 205,689
▲ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 204,689
▲ 46% vs 2024
Profit after tax over the fiscal year.
€ 104,729
▲ 251% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 140,416 paid out
69 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 31,840
▼ 12% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 145
▼ 75% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,467
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 76,602 | € 195,598 | € 192,202 | € 278,935 | ▲ 45% |
| Profit after taxes | € 58,294 | € 144,355 | € 140,416 | € 204,689 | ▲ 46% |
| Equity | € 117,973 | € 261,327 | € 141,416 | € 205,689 | ▲ 45% |
| Total debts | € 17,309 | € 31,034 | € 4,827 | € 22,562 | ▲ € 17,735 |
| Cash | € 89,212 | € 176,398 | € 29,852 | € 104,729 | ▲ 251% |
| Retained profit | € 115,973 | € 259,327 | € 139,416 | € 203,689 | ▲ 46% |
| Dividend | € 1,000 | € 1,000 | € 260,327 | € 140,416 | ▼ 46% |
| Balance sheet total | € 135,281 | € 292,361 | € 146,243 | € 228,251 | ▲ 56% |
Key figures of Dr. S Buggenhout, Reumatoloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. S Buggenhout, Reumatoloog the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. S Buggenhout, Reumatoloog?
What happened at Dr. S Buggenhout, Reumatoloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 204,689 (▲ 46% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Sint-Niklaas. KBO
- Saskia Buggenhout became a director. NBB
In short
From € 58,294 profit in 2022 to € 204,689 profit in 2025.
Paid € 160,035 in corporate taxes since 2022.
Best year ever: 2025, with € 204,689 profit.
Paid out € 402,744 in dividends to the owners in total.
Management
Behind Dr. S Buggenhout, Reumatoloog is Saskia Buggenhout.
Directors
According to the 2025 annual accounts
Saskia Buggenhout
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Bookmolenstraat 79
9111 Sint-Niklaas
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BUGGENHOUT Saskia Erika Lieve(oprichter) 100%
Details
- Company number
- 0757.628.002
- VAT number
- BE 0757.628.002
- Registered office
- Bookmolenstraat 79, 9111 Sint-Niklaas
- Names & denominations
- Dr. S Buggenhout, Reumatoloog
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 October 2020
- Peppol
- Active · Active since 18 Feb 2025